SGI
VIR icon

Summit Global Investments’s Vir Biotechnology VIR Stock Holding History

Summit Global Investments’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$355K Buy
+34,832
New +$331K 0.02% 411

Other funds holding VIR

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
SAI
Savvy Advisors Inc New York $4.71B AUM 25.36% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
OAM
OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return

Summit Global Investments's VIR Position: Q2 2026 in Review

Summit Global Investments opened a new position in Vir Biotechnology (VIR) in Q2 2026: 34,832 shares worth $355K. The stake represents 0.02% of the portfolio and ranks #411 among its holdings.

56 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Summit Global Investments held 34,832 shares of Vir Biotechnology worth $355K as of Q2 2026.
  • Vir Biotechnology was a new Summit Global Investments position in Q2 2026.
  • Vir Biotechnology made up 0.02% of Summit Global Investments's portfolio in Q2 2026, its #411 holding.
  • 56 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.